CRISPR-9
Latest
World's first in-human gene-editing treatment will tackle hemophilia
Hemophilia B is a terrifying disease. The livers of those suffering from the genetic disorder fail to produce a key protein called Factor IX, which is responsible for clotting blood. Without this protein, they're at constant risk of uncontrollable bleeding, including internally. However, a pair of researchers believe that their novel gene therapy could permanently cure the disease. To that end, the team of Michael Holmes and Thomas Wechsler from Richmond, California's Sangamo biopharmaceuticals, have announced that the world's first in-patient gene-editing therapy targeting these faulty genes will commence next week.
'Gene drive' mosquitoes could end malaria once and for all
The scourge of malaria could be going away for good in some regions, thanks to a groundbreaking discovery by researchers at the Universities of California, Irvine and San Diego. Their study, published Monday in the journal PNAS, has reportedly uncovered a method that all but guarantees that specific gene sets will be passed to offspring.
